Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00166283 · ClinicalTrials.gov registry record · NA
Improving New Learning and Memory in Multiple Sclerosis
A NA study, sponsored by Kessler Foundation.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
NCT00166283 is a NA study that has completed, run by Kessler Foundation. The registered enrollment target is 88 participants.
The verdict
NCT00166283, a NA study, has completed, sponsored by Kessler Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
Study Summary
The current study is a double-blind, placebo-control randomized clinical trial examining the efficacy of memory retraining in Multiple Sclerosis (MS). Impairment in higher level cognitive processing, such as new learning and memory, is one of the most common deficits in individuals with MS and such deficits have been shown to exert significant negative impact on multiple aspects of everyday life, including occupational and social functioning. Despite these findings, few studies have attempted to treat these cognitive deficits in order to improve the everyday functioning of individuals with MS. Through a small randomized clinical trial, we found that individuals with MS with documented memory impairment show a significant improvement in their memory performance following a treatment protocol designed to facilitate learning. The current proposal will replicate this finding and further evaluate (a) the impact of the treatment on everyday functioning, (b) the long term efficacy of the treatment and (c) the utility of booster sessions in facilitating long-term treatment effects. We will randomly assign individuals with MS, with documented impairment in new learning abilities, to a memory retraining group or a placebo control group. Both groups will undergo baseline, immediate and long-term follow-up assessment consisting of: (1) a traditional neuropsychological battery and (2) an assessment of global functioning examining the impact of the treatment on daily activities. This design will allow us to evaluate the efficacy of this particular memory retraining technique in an MS population through the assessment of cognitive function via a standard evaluation. In addition, we will be able to draw conclusions regarding the impact of this particular memory remediation program on everyday life from questionnaires completed by the participant and a significant other. Optional enrollment in pre- post neuroimaging will also allow us to look at changes in the brain.
Interventions
- BEHAVIORAL memory retraining exercises
- BEHAVIORAL placebo control memory exercises
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2005-02 |
| Est. Completion | 2011-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00166283
The ClinicalTrials.gov registry entry for NCT00166283 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kessler Foundation, which has 104 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which memory retraining exercises is the first listed.
NCT00166283 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00166283 about?
NCT00166283 is a clinical study titled "Improving New Learning and Memory in Multiple Sclerosis". The current study is a double-blind, placebo-control randomized clinical trial examining the efficacy of memory retraining in Multiple Sclerosis (MS). Impairment in higher level cognitive processing, such as new learning and memory, is one of the most common deficits in individuals with MS and such ...
What is the current status of trial NCT00166283?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2005-02. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00166283?
The interventions under investigation include: memory retraining exercises (BEHAVIORAL), placebo control memory exercises (BEHAVIORAL).
Who is sponsoring clinical trial NCT00166283?
This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.